Pricing Log in Create free account
Wednesday 4 November 2026 Export NOVT’s income statement to Excel — free account

Novanta Inc.

NOVT Technology Scientific & Technical Instruments

Novanta Inc.’s revenue for fiscal 2025 (year ended December 2025) was $980.6 million, up 3.30% from fiscal 2024.

Revenue
+10.3%
EPS
+158.3%
Free cash flow
+391.8%
Total debt
−50.0%

Quarter to June 2026, against a year earlier

144.88 2.61 −1.77%
Market cap
$5.6B
P/E
92.5×
Fwd P/E
80.1×
Dividend yield
—
F-score
5/9
Altman Z
6.64
Beneish M
−2.25
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Novanta Inc. 10-K filed Feb 23, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed · accepted 4:57 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1, Business, against the 10-K filed Feb 25, 2025: 6 added · 11 removed · 38 modified; 5 with only figures updated

  1. Modified · Overview

    Novanta Inc. and its subsidiaries (collectively referred to as the “Company”, “Novanta”, “we”, “us”, “our”) is a leading global supplier of core technology solutions that give medical , life science, and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges. This enables us to engineer core components and sub-systemsproprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications.